טוען...
SAHA-induced loss of the tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model
Thyroid cancer is on the rise. Novel approaches are needed to improve the outcome of patients with recurrent and advanced metastatic thyroid cancers. FDA approval of suberoylanilide hydroxamic acid (SAHA; vorinostat), an inhibitor of histone deacetylase, for the treatment of hematologic malignancies...
שמור ב:
| הוצא לאור ב: | Endocr Relat Cancer |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4959547/ https://ncbi.nlm.nih.gov/pubmed/27267120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-16-0103 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|